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• Hypothyroidism is a common condition with several 
manifestations in the GI tract including esophageal 
dysmotility, delayed gastric emptying, and 
diminished colonic motility 
• Pseudo-obstruction typically occurs in the critically 
ill, though the underlying pathophysiology is poorly 
understood, hypothyroidism can be the only pre-
disposing factor 
• Ogilvie's syndrome, or acute colonic pseudo-
obstruction (ACPO), is characterized by acute 
dilation of the colon, in the absence of a mechanical 
lesion, which obstructs the flow of intestinal contents
• We present a case of a 51 year-old woman 
presenting with symptoms of severe hypothyroidism 
found to have acute colonic pseudo-obstruction
History of Present Illness:
• 51 year-old woman presents with months of 
progressive weakness that acutely worsened 2 days 
prior to admission, is unable to get out of bed
Past Medical History: 
• BMI of 68, obstructive sleep apnea, diastolic heart 
failure, and hypothyroidism with prior medication 
non-adherence 
Physical Exam: 
• T 37.4, HR 71, BP 119/80, RR 20, SpO2 100% (RA)
• African American woman with BMI 68, no acute 
distress, cardiopulmonary exam unremarkable 
• Obese abdomen, soft, non-tender, with normoactive 
bowel sounds
Laboratory data: 
• CBC and CMP: within normal limits 
• TSH >150, FT4 <0.10
• Infectious studies including lactate, pro-calcitonin, 
blood cultures, urine cultures, viral panel negative
Acute Colonic Pseudo-Obstruction
• Case reports have demonstrated hypothyroidism as 
a known risk factor for ACPO
Pathophysiology of Pseudo-Obstruction
• Hypothesized to be caused by autonomic imbalance 
resulting in a hypotonic bowel
• ACPO is more common in the critically ill where 
sympathetic drive is high 
• Neostigmine, an acetylcholinesterase inhibitor and 
parasympathomimetic, is commonly used to reverse 
pseudo-obstruction 
• ACPO is likely driven by sympathetic excess
Management of ACPO
• Neostigmine can be given via bolus or infusion
• Neostigmine should be used with caution and often 
requires ICU monitoring given risk of precipitating 
bradycardia and bronchospasm
• In this case, given the patient’s operative risk 
factors, chemical decompression with neostigmine 
was administered and the patient improved. 
Several Days Later…
The patient becomes more encephalopathic
Repeat laboratory data reveals: 
• WBC and CMP unchanged 
• Pro-calcitonin elevated to 0.35
• Repeat blood, urinalysis and urine cultures negative, 
CXR without acute change, ABG normal 
CT abdomen and pelvis with and without contrast 
is obtained and reveals: 
• Massive dilation of the cecum measuring up to 17 
cm, transition to normal-caliber at the hepatic flexure 
without evidence of obstruction or stricture
Colonic Pseudo-Obstruction:
Before & After Neostigmine Decompression 
1. Before: CT revealing acute colonic pseudo-obstruction as evidenced by significant cecal dilation 
up to 17 cm (noted by white arrow)
2. After: CT after decompression with neostigmine revealing resolved dilation  
Before After
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Incidence of classic symptoms of acute colonic pseudo-
obstruction in a case series of 400 patients 
Symptom Incidence
Abdominal distention 100%
Abdominal pain 83%
Nausea 63%
Vomiting 57%
Constipation 51%
Diarrhea 47%
Fever 37%
Incidence of bowel tones in acute colonic pseudo-
obstruction
Normoactive 40%
Hypoactive 31%
Hyperactive 17%
Absent 12%
Risk Factors for ACPO
Manifestations of Hypothyroidism 
in the Gastrointestinal Tract
Esophageal Motility Disorders: 
• Achalasia, esophageal spasm and 
esophageal stricture
• Manifestations: dysphagia, heart burn
Dysregulation of microbiota: 
• Bacterial overgrowth
• Manifestations: abdominal distention, 
flatulence, bloating 
Delayed Gastric Emptying: 
• Gastroparesis 
• Manifestations: dyspepsia, nausea
Diminished Colonic Motility: 
• Constipation, ileus, megacolon, 
pseudo-obstruction and perforation
• Manifestations: abdominal pain, 
bloating, nausea/vomiting
Formulation Rate
Bolus 2mg over 15m
Infusion 5mg over 12 hours (0.4mg/h)
Acute Colonic Pseudo-Obstruction 
Management Algorithm
Pseudo-Obstruction 
Dilation <12 cm
Evaluate and treat reversible causes: 
• Electrolytes 
• Medications
• Infection
• Chronic disease management
24-48h conservative management:
NPO
NGT to suction
IVFs
Ambulation
Partial or no response
Dilation >12 cm
Partial or no response
Neostigmine 
Equal efficacy with bolus or infusion
May repeat 1x in <72 hours
Colonoscopic decompression 
Partial or no response
Poor surgical candidate
Percutaneous 
cecostomy tube
Laparotomy with 
resection 
Surgical candidate
Category Risk Factors
Surgical Cardiac, solid organ transplant,
orthopedic/spine
Cardiac/Respiratory Shock, MI, CHF, COPD
Neurological Dementia, Parkinson’s disease, Alzheimer’s 
disease, stroke
Metabolic Electrolyte imbalance, diabetes, renal failure, 
hepatic failure
Medications Opiates, anticholinergics, antipsychotics, 
cytotoxins, clonidine 
Infection VZV, herpes, CMV
Miscellaneous Trauma, burns, severe sepsis, idiopathic 
